Advertisement

Strahlentherapie und Onkologie

, Volume 174, Issue 8, pp 438–438 | Cite as

Verzögerung der Progredienz von Knochenmetastasen bei Mammakarzinompatientinnen durch intravenöse Pamidronat-behandlung: Ergebnisse einer randomisierten, kontrollierten, multinationalen Studie

  • Irenäus A. Adamietz
Literatur Kommentiert

Literatur

  1. 1.
    Berenson JR, Lichtenstein A, Porter L, et al. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. New Engl J Med 1996;334:488–93.PubMedCrossRefGoogle Scholar
  2. 2.
    Conte PF, Latreille J, Mauriac L, et al. Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. J Clin Oncol 1996;14:2552–9.PubMedGoogle Scholar
  3. 3.
    Fleisch H. Bisphosphonates in bone disease, 2nd edn, New York-London. Parthenon, 1995.Google Scholar
  4. 4.
    Hortobagvi GN, Theriault RL, Lester Porter DO, et al. (for the Protocol 19 Aredia Breast Cancer Study Group). Efficacy of pamidronate in reducing skeletal complications in patients with breat cancer and lytic bone metastases. New Engl J Med 1996;335:1785–91.CrossRefGoogle Scholar

Copyright information

© Urban & Vogel 1998

Authors and Affiliations

  • Irenäus A. Adamietz
    • 1
  1. 1.Frankfurt a. Main

Personalised recommendations